Why Theranos Should Return Its Capital To Investors

Posted on by

Theranos, the formerly $9 billion company that FORBES revalued in July at $800 million, will shutter all its blood testing facilities.

from Forbes – Tech http://ift.tt/2dK6p1c
via IFTTT